Get the Stockscreener App
339.61
0.16%
-0.55
Pre-market:
338.71
-0.90
-0.27%
Penumbra Inc stock is traded at $339.61, with a volume of 720.63K.
It is down -0.16% in the last 24 hours and down -0.09% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$340.16
Open:
$341.52
24h Volume:
720.63K
Relative Volume:
0.77
Market Cap:
$13.32B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
320.39
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
+0.28%
1M Performance:
-0.09%
6M Performance:
+21.41%
1Y Performance:
+19.74%
1-Day Range:
$338.61
$341.52
1-Week Range:
$338.61
$344.53
52-Week Range:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
339.61 | 13.34B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Insider Sell: Maggie Yuen Sells Shares of Penumbra Inc (PEN) - GuruFocus
NZS Capital LLC Buys 17,355 Shares of Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (NYSE: BSX) Explains Rationale for Penumbra Deal - Stock Titan
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGT - Carroll County Mirror-Democrat
Champlain Investment Partners LLC Trims Holdings in Penumbra, Inc. $PEN - MarketBeat
Broker files Form 144 reporting PEN share sales (NYSE: PEN) - Stock Titan
(PEN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise - The Globe and Mail
Penumbra, Inc. (PEN) Stock Analysis: Unveiling the Potential in Medical Devices with a 4.57% Upside - DirectorsTalk Interviews
Citigroup Inc. Grows Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
TD Asset Management Inc Sells 8,742 Shares of Penumbra, Inc. $PEN - MarketBeat
Artisan Partners Limited Partnership Raises Position in Penumbra, Inc. $PEN - MarketBeat
PEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Penumbra, Inc. $PEN Shares Acquired by Intech Investment Management LLC - MarketBeat
UBS Maintains Neutral on Penumbra (PEN) Feb 26, 2026 - Meyka
Penumbra (PEN) Earnings Surge Challenges Concerns Over Rich 75x P/E Valuation - simplywall.st
UBS reiterates Neutral on Penumbra stock, keeps $374 target By Investing.com - Investing.com Canada
Evercore ISI Maintains Outperform Rating and Raises PT for PEN t - GuruFocus
UBS reiterates Neutral on Penumbra stock, keeps $374 target - Investing.com
Penumbra, Inc. (NYSE:PEN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Decoding Penumbra Inc (PEN): A Strategic SWOT Insight - GuruFocus
Boston Scientific Still Navigating the Regulatory Process to Acquire Penumbra - Morningstar
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | BSX Stock News - Longbridge
Evercore ISI Maintained Outperform for Penumbra, Inc. (PEN) Feb 25, 2026 - Meyka
Evercore ISI raises Penumbra stock price target on embolization growth - Investing.com Nigeria
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025 - Finviz
Evercore ISI raises Penumbra stock price target on embolization growth By Investing.com - Investing.com South Africa
Penumbra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financi - GuruFocus
Penumbra: Fourth Quarter Earnings Overview - Bitget
Penumbra (NYSE:PEN) Announces Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Penumbra Inc SEC 10-K Report - TradingView
Penumbra: Q4 Earnings Snapshot - marketscreener.com
Penumbra Q4 Non-GAAP Earnings, Revenue Rise - marketscreener.com
Penumbra Inc. (PEN) Releases Q4 2025 Earnings: Revenue and EPS Beat, Strong YoY Growth - Quiver Quantitative
Earnings Flash (PEN) Penumbra, Inc. Reports Q4 Revenue $385.4M, vs. FactSet Est of $361.9M - marketscreener.com
Earnings Flash (PEN) Penumbra, Inc. Posts Q4 Adjusted EPS $1.18 per Share, vs. FactSet Est of $1.11 - marketscreener.com
Penumbra Q4 Earnings Assessment - Benzinga
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Penumbra (NYSE: PEN) grows 2025 revenue 17.5% amid BSX acquisition - Stock Titan
Penumbra Inc (NYSE:PEN) Combines Strong Fundamentals with Bullish Technical Setup - ChartMill
Penumbra, Inc. (PEN) Stock Analysis: Navigating Healthcare Innovation with a 2.70% Upside - DirectorsTalk Interviews
Penumbra earnings on deck as Boston Scientific deal looms By Investing.com - Investing.com South Africa
PEN (Penumbra) Retained Earnings : $190 Mil (As of Sep. 2025) - GuruFocus
PEN (Penumbra) Sale Of Investment : $18 Mil (TTM As of Sep. 2025) - GuruFocus
Chipmakers Recap: Is Penumbra Inc on track to beat earnings2025 Major Catalysts & Safe Capital Allocation Plans - baoquankhu1.vn
Vanguard Group Inc. Sells 25,172 Shares of Penumbra, Inc. $PEN - MarketBeat
Analysts Offer Insights on Healthcare Companies: Penumbra (PEN), Orchestra BioMed Holdings (OBIO) and Teladoc (TDOC) - The Globe and Mail
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape - FinancialContent
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):